Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2000
08/17/2000WO2000047728A2 Soybean glutathione-s-transferase enzymes
08/17/2000WO2000047727A2 Nucleic acid molecules encoding alternansucrase
08/17/2000WO2000047726A2 Plant polyphenol oxidase homologs
08/17/2000WO2000047725A1 Nitroreductase enzymes
08/17/2000WO2000047724A2 Methods to mediate polyketide synthase module effectiveness
08/17/2000WO2000047723A2 Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same
08/17/2000WO2000047717A1 Avian pluripotent embryonic germ cell line
08/17/2000WO2000047715A2 Dwf4 polynucleotides, polypeptides and uses thereof
08/17/2000WO2000047714A2 Isolation and characterization of heat shock protein
08/17/2000WO2000047713A2 Genes encoding the 5h7 antibody and methods for conferring programmed cell death properties to cells
08/17/2000WO2000047625A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000WO2000047622A2 Peptides with anti-angiogenic activity
08/17/2000WO2000047619A1 Therapeutics and diagnostics based on an il-1b mutation
08/17/2000WO2000047618A2 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES
08/17/2000WO2000047617A1 Human uncoupling proteins and polynucleotides encoding the same
08/17/2000WO2000047616A1 Tpaace06: human ptd016 gene
08/17/2000WO2000047615A2 Proteins related to neuronal regeneration and uses thereof
08/17/2000WO2000047614A1 Transgenic plants with modified expression of the dp protein
08/17/2000WO2000047612A2 Structure-based screening techniques for drug discovery
08/17/2000WO2000047611A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/17/2000WO2000047610A2 Method for altering undesirable immune responses to polypeptides
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047599A1 Novel nucleosides and oligonucleotide analogues
08/17/2000WO2000047317A1 Method for producing addressed ligand matrixes on a support
08/17/2000WO2000047231A2 Novel antisense inhibition of rad51
08/17/2000WO2000047229A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
08/17/2000WO2000047223A2 Viral vaccine
08/17/2000WO2000047175A1 Oral compositions and methods of production thereof
08/17/2000WO2000038838A8 Apparatus and methods for efficient processing of biological samples on slides
08/17/2000WO2000037649A3 Dna vaccine against infectious bursal disease virus
08/17/2000WO2000034473A3 Seven transmembrane domain receptor zsig56
08/17/2000WO2000034449A8 UDP-N- ACETYL GLUCOSAMINE: GALACTOSE-β1, 3-N- ACETYL GALACTOSAMINE- α-R/ N- ACETYL GLUCOSAMINE -β1, 3-N- ACETYL GALACTOSAMINE- α-R (GlcNAc TO GalNAc) β1,6-N- ACETYL GLUCOSAMINYL TRANSFERASE, C2/4GnT
08/17/2000WO2000034317A3 Method for reducing immunogenicity of proteins
08/17/2000WO2000033870A3 New cancer treatments
08/17/2000WO2000031273A3 Process for oxidising terpenes
08/17/2000WO2000031246A3 Methods for the preparation by in vivo recombination of nucleic acid and polypeptide libraries and uses thereof
08/17/2000WO2000030590A3 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
08/17/2000WO2000028080A3 Methods, software and apparati for identifying genomic regions harboring a gene associated with a detectable trait
08/17/2000WO2000028053A3 Plant glutamine amidotransferase homologs
08/17/2000WO2000027340A3 USE OF t-RNA AND FRAGMENTS FOR INHIBITING ANGIOGENESIS AND COMPOSITIONS THEREOF
08/17/2000WO2000026375A3 Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains
08/17/2000WO2000026374A3 Adipose specific protein
08/17/2000WO2000024769A3 Process for recovering heterologous polypeptide from bacterial refractile particles
08/17/2000WO2000024766A3 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
08/17/2000WO2000023616A3 Method for the exponential amplification of molecular matrices
08/17/2000WO2000022145A3 A hydroperoxide lyase gene from maize and methods of use
08/17/2000WO2000021574A3 Site-directed dual pegylation of proteins
08/17/2000WO2000020602A3 Delta 6 and delta 12 desaturases and modified fatty acid biosynthesis and products produced therefrom
08/17/2000WO2000018912A3 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases
08/17/2000WO2000017643A9 A system for cell-based screening
08/17/2000WO2000017356A3 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses therof
08/17/2000WO2000017323A9 Stable neural stem cell lines
08/17/2000WO2000016089A9 Signal detection techniques for the detection of analytes
08/17/2000WO2000015816A9 Maize replication protein a
08/17/2000WO2000015784A3 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
08/17/2000WO2000015773A3 Inhibition of oncogene transcription by synthetic polyamides
08/17/2000WO2000015665A3 A method of producing a functional immunoglobulin superfamily protein
08/17/2000WO2000014267A8 Biosensor
08/17/2000WO2000014263A3 Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them
08/17/2000WO2000014262A9 Methylation of plasmid vectors
08/17/2000WO2000014230A9 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
08/17/2000WO2000014207A3 Plant farnesyltransferases
08/17/2000WO2000013796A9 Capillary printing systems
08/17/2000WO2000013026A9 Energy transfer dyes
08/17/2000WO2000012711A3 Human membrane channel proteins
08/17/2000WO2000005393A3 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)
08/17/2000WO1999064594A3 Genes and gene expression products that are differentially regulated in prostate cancer
08/17/2000WO1999062316A3 Identification of lactic acid bacteria genes involved in the biosynthesis of exopolysaccharides
08/17/2000WO1998015626A3 Mutant ciita molecule and uses thereof
08/17/2000DE19956568A1 Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens Method and medicament for the inhibition of expression of a given gene
08/17/2000DE19907470A1 Verfahren zur Auftrennung von in Lösung befindlichen doppelsträngigen Nukleinsäuren in einzelsträngige Nukleinsäuren A process for the separation of double stranded nucleic acids in solution in single stranded nucleic acids
08/17/2000DE19906096A1 Protein mit einem Heparin-bindenden Epitop Protein having a heparin-binding epitope
08/17/2000DE19905501A1 Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels A method of producing a recombinant adeno-associated virus, as well as suitable means to this end use for the preparation of a medicament
08/17/2000DE19904650A1 cDNA-Sequenz eines Interaktors FANCIP1 des Fanconi-Anämie-Proteins der Komplementationsgruppe A cDNA sequence of an interactor FANCIP1 of the Fanconi anemia complementation group A protein
08/17/2000DE19900638A1 Methode zur Isolierung von DNA aus biologischen Materialien Method for the isolation of DNA from biological materials
08/17/2000DE19855489A1 New nucleic acid molecule comprising simian virus 40 regulatory sequences and antibiotic resistance gene, useful for expressing erythropoietin in mammalian cells for treating anemia
08/17/2000CA2716429A1 Udp-glucose modifiers
08/17/2000CA2366487A1 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
08/17/2000CA2364615A1 Haemophilus influenzae rd outer membrane sequences used as vaccine
08/17/2000CA2362612A1 Crystal structure of cpla2, and methods of identifying agonists and antagonists using same
08/17/2000CA2362603A1 Dwf4 polynucleotides, polypeptides and uses thereof
08/17/2000CA2362592A1 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000CA2362586A1 Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism
08/17/2000CA2362541A1 Structure-based screening techniques for drug discovery
08/17/2000CA2362524A1 The ltr region of msrv-1 and the proteins it encodes, and probes and methods for detecting msrv-1 retrovirus
08/17/2000CA2362523A1 Nitroreductase enzymes
08/17/2000CA2362373A1 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/17/2000CA2362368A1 Method for altering undesirable immune responses to polypeptides
08/17/2000CA2362295A1 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
08/17/2000CA2362109A1 Novel antisense inhibition of rad51
08/17/2000CA2361384A1 High throughput mass spectrometry
08/17/2000CA2361335A1 Inhibiting formation of atherosclerotic lesions
08/17/2000CA2361334A1 Deglycosylated kringle 1-3 region fragments of plasminogen and methods of use
08/17/2000CA2361293A1 33 human secreted proteins
08/17/2000CA2361034A1 Proteins related to neuronal regeneration and uses thereof
08/17/2000CA2360416A1 Nac1 - a plant gene encoding a transcription factor involved in cotyledon and lateral root development
08/17/2000CA2360103A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha
08/17/2000CA2359803A1 Udp-glucose epimerases
08/17/2000CA2359801A1 Methods to mediate polyketide synthase module effectiveness
08/17/2000CA2359799A1 Neisseria meningitidis serogroup b antigen
1 ... 3198 3199 3200 3201 3202 3203 3204 3205 3206 3207 3208 3209 3210 3211 3212 3213 3214 3215 3216 3217 3218 ... 4023